Trump’s MFN Drug Pricing Policy Is Reshaping Pharmaceutical Markets
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
Pricing and Reimbursement
We provide assistance to our clients at all stages of the price and reimbursement application process.
Generally, from the patients’ perspective, the market access of an outpatient medicinal product requires that a product is reimbursed through health insurance. Optimally, the new drug will be available to patients in need as quickly and extensively as possible and at a competitive price. The price and reimbursement application process plays an important role in this.
To do this, we provide assistance to our clients at all stages of the price and reimbursement application process. The service is tailored to meet our customer’s needs. We provide assistance to help you through the whole application process, from health economic evaluation and RWE studies to smaller consultation assistance at different stages of application processes.
Our comprehensive pricing and reimbursement services include:
- Providing strategic and tactical counseling in the different phases of the pricing and reimbursement application process
- Preparing and compiling basic and special reimbursement applications for medicinal products containing a new active ingredient, applications for renewal and extension, and applications concerning a new strength, package size and pharmaceutical form
- This also includes the health economic studies required for the application as well as any needed RWE studies
- Providing expert assistance and advice on risk-sharing agreements and contractual arrangements for conditional reimbursement
A typical pricing and reimbursement project
Read more:
Read an overview of the Finnish market access and pricing system – This article outlines how healthcare is organized, how decisions are made, and which public bodies are involved, providing clear background context for companies seeking to familiarize themselves with Finland’s regulatory and reimbursement environment.
Pharmaceuticals Pricing Board – www.hila.fi
Kela – Reimbursement for medicine expenses
Contact us!
Related articles
-
-
Medaffcon Makes Medtech Measurable When Data Determines Market Access
Medaffcon brings to the health technology market the kind of effectiveness and cost-conscious thinking well established in the pharmaceutical industry.
-
Medaffcon Contributes to the Public Good through Academic Collaboration
While the majority of Medaffcon’s revenue comes from the pharmaceutical industry, the company’s activities are not limited only to commercial projects. At any given time, several academic projects may be ongoing.
